The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com:
- Axillary Reverse Mapping for Prevention of Breast Cancer Related Lymphedema
- Breast Ductal Lavage for Detection of Breast Cancer
- Buprenorphine for Treatment of Opioid Dependence
- Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)
- Dermatologic Applications of Photodynamic Therapy
- Dry Hydrotherapy for Chronic Pain Conditions
- Dynamic Spinal Visualization and Vertebral Motion Analysis
- Electrogastrography (EGG)
- Endometrial Ablation
- Gene Therapies for Duchenne Muscular Dystrophy
- Home Spirometry
- Home Uterine Activity Monitoring
- Human Leukocyte Antigen Testing Mandate
- Ingestible pH and Pressure Capsule
- Laboratory Testing Investigational Services
- Laser Treatment for Onychomycosis
- Magnetic Esophageal Sphincter Augmentation to Treat GERD
- Measurement of Serum Antibodies to Selected Biologic Agents
- Mental Illness and Substance Use Disorders Mandate
- Molecular Testing for the Management of Pancreatic Cysts and Solid Pancreaticobiliary Lesions
- Monitored Anesthesia Care for Gastrointestinal Endoscopic Procedures
- Nerve Graft with Radical Prostatectomy
- Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy
- Percutaneous Revascularization Procedures for Lower Extremity Peripheral Arterial Disease
- Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia and Gastroparesis
- Plugs for Anal Fistula Repair
- Prostatic Stent – Temporary
- Reflectance Confocal Microscopy for Evaluating Skin Lesions for Suspected Malignancy
- Serum Biomarker Human Epididymis Protein 4
- Sphenopalatine Ganglion Block for Headache
- Thermal Capsulorrhaphy as a Treatment of Joint Instability
- Topographic Brain Mapping
- Transcranial Magnetic Stimulation (TMS) as a Treatment of Depression and Other Psychiatric-Neurologic Disorders
- Treatment for Duchenne Muscular Dystrophy
We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the “Draft Medical Policies” drop-down.